TrialNature medicine2024

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Feng Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.